Bristol Myers hunches down at the offers table, carrying out a brand-new I/O play in biotech acquistion

0
1
Loading ....

In a large action towards its $10 billion divestment objective, Takeda struck an offer to market its Japanese customer health care organisation, recognized for non-prescription items, to United States personal equity company Blackstone …
Read More

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here